Use of lectins as diagnostic and therapeutic tools for cancer

Rustom Mody, Shantaram S Joshi, William G Chaney

Research output: Contribution to journalReview article

123 Citations (Scopus)

Abstract

Within the past few years, lectins have become a well-established means for understanding varied aspects of cancer and metastasis. Evidence is now emerging that lectins are dynamic contributors to tumor cell recognition (surface markers), cell adhesion and localization, signal transduction across membranes, mitogenic stimulation, augmentation of host immune defense, cytotoxicity, and apoptosis. To advance understanding of these lectin-dependent processes, attempts are being made to discover new lectins that have one or more of these functions and to develop lectin- (or glycoconjugate-) based tools that could be used to home in on tumor cells. This review will summarize current research on the lectins and recent advances in the development of lectin-based diagnostic and therapeutic tools for cancer. Additionally, the future potential of lectin-based diagnosis and therapy is discussed.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalJournal of Pharmacological and Toxicological Methods
Volume33
Issue number1
DOIs
StatePublished - Feb 1995

Fingerprint

Lectins
Neoplasms
Therapeutics
Tumors
Cells
Signal transduction
Glycoconjugates
Cell adhesion
Cytotoxicity
Cell Adhesion
Signal Transduction
Apoptosis
Neoplasm Metastasis
Membranes
Research

Keywords

  • Cancer
  • Diagnosis
  • Glycoconjugates
  • Lectins
  • Metastasis
  • Therapy

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Use of lectins as diagnostic and therapeutic tools for cancer. / Mody, Rustom; Joshi, Shantaram S; Chaney, William G.

In: Journal of Pharmacological and Toxicological Methods, Vol. 33, No. 1, 02.1995, p. 1-10.

Research output: Contribution to journalReview article

@article{7e9b4e78461b413b9d00379492ac5b8c,
title = "Use of lectins as diagnostic and therapeutic tools for cancer",
abstract = "Within the past few years, lectins have become a well-established means for understanding varied aspects of cancer and metastasis. Evidence is now emerging that lectins are dynamic contributors to tumor cell recognition (surface markers), cell adhesion and localization, signal transduction across membranes, mitogenic stimulation, augmentation of host immune defense, cytotoxicity, and apoptosis. To advance understanding of these lectin-dependent processes, attempts are being made to discover new lectins that have one or more of these functions and to develop lectin- (or glycoconjugate-) based tools that could be used to home in on tumor cells. This review will summarize current research on the lectins and recent advances in the development of lectin-based diagnostic and therapeutic tools for cancer. Additionally, the future potential of lectin-based diagnosis and therapy is discussed.",
keywords = "Cancer, Diagnosis, Glycoconjugates, Lectins, Metastasis, Therapy",
author = "Rustom Mody and Joshi, {Shantaram S} and Chaney, {William G}",
year = "1995",
month = "2",
doi = "10.1016/1056-8719(94)00052-6",
language = "English (US)",
volume = "33",
pages = "1--10",
journal = "Journal of Pharmacological and Toxicological Methods",
issn = "1056-8719",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Use of lectins as diagnostic and therapeutic tools for cancer

AU - Mody, Rustom

AU - Joshi, Shantaram S

AU - Chaney, William G

PY - 1995/2

Y1 - 1995/2

N2 - Within the past few years, lectins have become a well-established means for understanding varied aspects of cancer and metastasis. Evidence is now emerging that lectins are dynamic contributors to tumor cell recognition (surface markers), cell adhesion and localization, signal transduction across membranes, mitogenic stimulation, augmentation of host immune defense, cytotoxicity, and apoptosis. To advance understanding of these lectin-dependent processes, attempts are being made to discover new lectins that have one or more of these functions and to develop lectin- (or glycoconjugate-) based tools that could be used to home in on tumor cells. This review will summarize current research on the lectins and recent advances in the development of lectin-based diagnostic and therapeutic tools for cancer. Additionally, the future potential of lectin-based diagnosis and therapy is discussed.

AB - Within the past few years, lectins have become a well-established means for understanding varied aspects of cancer and metastasis. Evidence is now emerging that lectins are dynamic contributors to tumor cell recognition (surface markers), cell adhesion and localization, signal transduction across membranes, mitogenic stimulation, augmentation of host immune defense, cytotoxicity, and apoptosis. To advance understanding of these lectin-dependent processes, attempts are being made to discover new lectins that have one or more of these functions and to develop lectin- (or glycoconjugate-) based tools that could be used to home in on tumor cells. This review will summarize current research on the lectins and recent advances in the development of lectin-based diagnostic and therapeutic tools for cancer. Additionally, the future potential of lectin-based diagnosis and therapy is discussed.

KW - Cancer

KW - Diagnosis

KW - Glycoconjugates

KW - Lectins

KW - Metastasis

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0028872958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028872958&partnerID=8YFLogxK

U2 - 10.1016/1056-8719(94)00052-6

DO - 10.1016/1056-8719(94)00052-6

M3 - Review article

C2 - 7727802

AN - SCOPUS:0028872958

VL - 33

SP - 1

EP - 10

JO - Journal of Pharmacological and Toxicological Methods

JF - Journal of Pharmacological and Toxicological Methods

SN - 1056-8719

IS - 1

ER -